首页> 外国专利> METHOD FOR CONTROLLING DIFFERENTIATION OF EMBRYONIC STEM CELLS INTO ADIPOCYTES OR KIDNEY PRECURSOR CELLS BY REGULATING SIRT1 EXPRESSION

METHOD FOR CONTROLLING DIFFERENTIATION OF EMBRYONIC STEM CELLS INTO ADIPOCYTES OR KIDNEY PRECURSOR CELLS BY REGULATING SIRT1 EXPRESSION

机译:通过调节SIRT1表达来控制胚胎干细胞分化为脂肪细胞或肾前体细胞的方法

摘要

The present invention relates to a method for controlling the differentiation of embryonic stem cells into adipocytes or kidney precursor cells by regulating SIRT1 (silent mating type information regulation 2 homolog; sirtuin 1) expression, the method, which controls the differentiation of embryonic stem cells into adipocytes by regulating SIRT1 expression, being capable of controlling the inhibition or promotion of adipocyte differentiation in accordance with the timing of a SIRT1 expression inhibitor treatment. Furthermore, kidney precursor cell differentiation can be regulated by a SIRT1 expression inhibitor or promoter treatment. Accordingly, a SIRT1 inhibitor can be selected to be used as an inhibitor or a therapeutic agent for obesity, diabetes accompanying obesity, and renal and metabolic diseases.
机译:本发明涉及通过调节SIRT1(沉默交配型信息调节2同源物; sirtuin 1)的表达来控制胚胎干细胞向脂肪细胞或肾前体细胞的分化的方法,该方法控制胚胎干细胞向通过调节SIRT1表达来控制脂肪细胞,其能够根据SIRT1表达抑制剂治疗的时间来控制对脂肪细胞分化的抑制或促进。此外,可以通过SIRT1表达抑制剂或启动子处理来调节肾脏前体细胞的分化。因此,可以选择SIRT1抑制剂用作肥胖症,伴随肥胖症的糖尿病以及肾和代谢疾病的抑制剂或治疗剂。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号